Dr. Garfall on Impact of CAR T-Cell Therapy in Hematologic Malignancies – OncLive
|
Dr. Garfall on Impact of CAR T-Cell Therapy in Hematologic Malignancies
OncLive This type of treatment has also come into clinical application use in the last 5 years with pilot and multicenter studies that are targeting CD19 with CAR T cells in patients with various B-cell malignancies, he adds. Another target includes BCMA in … |
